Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE3
Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3